ICICI Prudential Nifty G-Sec Dec 2030 Index Fund
Direct Plan · Annual IDCW · ICICI Prudential Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +0.70% | +3.19% | 214 of 283 |
| 1M | +0.37% | +2.85% | 212 of 283 |
| 3M | -0.45% | -2.37% | 85 of 283 |
| 6M | +2.57% | +1.56% | 90 of 278 |
| YTD | +2.86% | -0.86% | 98 of 283 |
| 1Y | +3.59% | -0.15% | 77 of 263 |
| 2Y | +6.17% | +2.58% | 58 of 193 |
| 3Y | +7.39% | +9.71% | 105 of 142 |
| INCEPTION | +7.45% | — | — |
Ranked among: Other Scheme - Index Funds.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +1.87% | +4.99% | -1.08% | 95% | 38% |
| 6M | +3.81% | +7.24% | +0.10% | 100% | 41% |
| 1Y | +7.88% | +12.22% | +2.71% | 100% | 43% |
| 2Y | +8.34% | +9.84% | +5.73% | 100% | 43% |
| 3Y | +7.92% | +8.96% | +7.04% | 100% | 43% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity0.00%
- Debt95.97%
- Cash4.02%
- Other0.01%
Market Cap Split
- Large Cap0.00%
- Mid Cap0.00%
- Small Cap0.00%
- Others100.00%
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| 897GOI2030 | SOV | 65.20% | +0.00% |
| 920GOI2030 | SOV | 24.52% | -0.04% |
| 788CG2030 | SOV | 3.05% | +0.02% |
| TREPS | Reverse Repo / TREPS | 2.20% | — |
| Net Current Assets | Net Current Assets | 1.82% | — |
| GOI LOAN 5.85% 2030 | SOV | 1.20% | +0.00% |
| GOI LOAN 5.77% 2030 | SOV | 1.08% | -1.19% |
| 761CG2030 | SOV | 0.87% | +0.00% |
| 579GOI2030 | SOV | 0.05% | +0.00% |
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 2.50 | 12.38 | Low Volatility |
| 3Y | 2.00 | 10.25 | Low Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.98 | -0.51 | Below Average |
| 3Y | 0.61 | 0.26 | Above Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 2.28 | 12.56 | Below Average |
| 3Y | 6.19 | 8.16 | Below Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Tracking Difference
Versus Nifty G-sec Dec 2030 Index, as of Sep 2026.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
ICICI Prudential Nifty Pharma Index Fund
Direct Plan · IDCW
|
+22.53% | +22.50% | — | +21.44% |
|
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
Direct Plan · Growth
|
+20.88% | +21.50% | +14.91% | +16.74% |
|
Tata Nifty Capital Markets Index Fund
Direct Plan · Growth Option
|
+19.89% | — | — | +21.71% |
|
Motilal Oswal Nifty Capital Market Index Fund
Regular Plan · Growth
|
+19.31% | — | — | +16.06% |
|
Motilal Oswal S&P 500 Index Fund
Direct Plan · GROWTH
|
+18.19% | +25.74% | +16.20% | +20.46% |
|
Tata Nifty MidSmall Healthcare Index Fund
Regular Plan · IDCW Payout Option
|
+17.24% | — | — | +17.73% |
|
Motilal Oswal Nifty MidSmall Healthcare Index Fund
Regular Plan · Growth
|
+17.19% | — | — | +11.55% |
|
ICICI Prudential NASDAQ 100 Index Fund
Regular Plan · Growth
|
+15.21% | +27.99% | +16.74% | +17.49% |
|
Bandhan BSE Healthcare Index Fund
Regular Plan · Growth
|
+13.22% | — | — | +7.26% |
|
Motilal Oswal Nifty India Defence Index Fund
Regular Plan · Growth
|
+13.06% | — | — | +4.19% |
More From ICICI Prudential Asset Management Company Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
ICICI Prudential Strategic Metal and Energy Equity Fund of Fund
Direct Plan · IDCW
|
+54.73% | +34.44% | — | +28.69% |
| ICICI PRUDENTIAL SILVER ETF | +26.35% | +36.57% | — | +24.10% |
|
ICICI Prudential Silver ETF FOF
Direct Plan · IDCW
|
+25.48% | +35.58% | — | +24.36% |
|
ICICI Prudential Nifty Pharma Index Fund
Direct Plan · IDCW
|
+22.53% | +22.50% | — | +21.44% |
|
ICICI Prudential Global Stable Equity Fund (FOF)
Direct Plan · Growth
|
+21.49% | +15.76% | +11.03% | +10.51% |
|
ICICI Prudential US Bluechip Equity Fund
Direct Plan · IDCW
|
+21.29% | +19.31% | +13.10% | +16.61% |
| ICICI Prudential Nifty Metal ETF | +19.46% | — | — | +16.41% |
|
ICICI Prudential Gold ETF FOF
Direct Plan · Growth
|
+17.38% | +30.99% | +23.18% | +10.56% |
| ICICI Prudential Gold ETF | +16.94% | +31.16% | +23.37% | +12.02% |
|
ICICI Prudential NASDAQ 100 Index Fund
Direct Plan · Growth
|
+15.77% | +28.57% | +17.30% | +18.04% |
About This Scheme
Investment Objective
The investment objective of the scheme is to track the Nifty G-sec Dec 2030 Index by investing in Government Securities, maturing on or before Dec 2030, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved and the scheme does not assure or guarantee any returns.
Stated Asset Allocation
• Government Securities (G-sec) forming part of Nifty G-sec Dec 2030 Index= 95-100 • Money Market instruments including cash and cash equivalents (Treasury Bills, Government Securities with residual maturity of upto 1 year and Tri- Party Repos) = 0-5 • Units of Debt schemes = 0-5
Exit Load
Nil
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch